M. Yamaoka

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

I. Shimomura, H. Kaneto, T. Matsuoka, 2021, Diabetes Therapy.

Antihypertensive agents prescribed for patients undergoing dialysis therapy: a multicenter survey

S. Okuno, S. Hirata, Hiroya Masuda, 2004 .

Clinical Evaluation of Maxacalcitol as a Therapy for Secondary Hyperthyroidism

Kazuhiko Tanaka, M. Yamaoka, Yasuyuki Ozato, 2003 .

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

I. Shimomura, H. Kaneto, T. Matsuoka, 2023, Cardiovascular Diabetology.